DepoMed, Inc.: Loeb's Third Point Discloses 8.2% Stake
May 15, 2007
| about: DEPO
-
Font Size:
-
Print
- TweetThis
In a 13G filing after the close Friday, Daniel Loeb's Third Point LLC disclosed an 8.2% stake in DepoMed Inc. (DEPO). The firm did not show a stake in DEPO for the quarter ended 12/31/06.
A 13G indicates a "passive" stake, but Loeb is known as a activist investor.
Depomed, Inc., is a specialty pharmaceutical company with two approved products on the market and multiple product candidates in its pipeline.
Related Articles
|

























